New guideslines proposed by the US Preventive Services Task Force sponsored by the Agency for Health Research and Quality would increase the number of women eligible for bone density tests to detect osteoporosis.
A new set of guidelines proposed by the US Preventive Services Task Force sponsored by the Agency for Health Research and Quality would increase the number of women eligible for bone density tests to detect osteoporosis.
Both the existing and the proposed guidelines recommend that all women be screened for osteoporosis starting at age 65. However, the proposed guidelines recommend that women identified to be at higher risk for osteoporosis should be screened at any age rather than waiting until age 60, as set forth in the 2002 guidelines.
To develop the new recommendations, researchers reviewed the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews, MEDLINE, reference lists, and the Web of Science for studies related to osteoporosis screening and medications with fracture outcomes; performance studies of validated risk-assessment instruments; and systematic reviews and population-based studies of bone measurement tests or medication adverse effects published from January 2001 to December 2009. Data on patient populations, study design, analysis, follow-up, and results were abstracted and study-quality rated by standard criteria.
The newest guidelines still do not recommend testing men for the disease, although the National Osteoporosis Foundation recommends doing so starting at age 70.
Nelson HD, Haney EM, Dana T, Bougatsos C, Choi R. Screening for osteoporosis: an update for the US Preventive Services Task Force. Ann Intern Med. 2010;153(2):99-111.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More